CIK: 0001643354 · Show all filings
Period: Q2 2025 (← Previous) (Next →)
Filing Date: Aug 14, 2025
Total Value ($000): $14,729 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| FENC | FENNEC PHARMACEUTICALS INC | 195,700 | $1,624 | 11.0% | $8.27 | -17.3% | COM | 31447P100 |
| ARDX | ARDELYX INC | 335,400 | $1,315 | 8.9% | $1.61 | +155.8% | COM | 039697107 |
| KNSA | KINIKSA PHARMACEUTICALS INTL | 45,900 | $1,270 | 8.6% | $18.73 | +35.9% | ORD SHS CL A | G52694109 |
| BBIO | BRIDGEBIO PHARMA INC | 26,000 | $1,123 | 7.6% | $27.34 | +33.0% | COM | 10806X102 |
| INSM | INSMED INC | 10,650 | $1,072 | 7.3% | $21.50 | +255.7% | COM PAR $.01 | 457669307 |
| MLYS | MINERALYS THERAPEUTICS INC | 79,000 | $1,069 | 7.3% | $12.41 | +16.8% | COM | 603170101 |
| MIST | MILESTONE PHARMACEUTICALS IN | 548,806 | $1,065 | 7.2% | $3.14 | -57.5% | COM | 59935V107 |
| — | AVADEL PHARMACEUTICALS PLC | 98,700 | $873 | 5.9% | $11.87 | — | COM SHS | G29687103 |
| JSPR | JASPER THERAPEUTICS INC | 146,500 | $813 | 5.5% | $9.08 | -45.8% | COM NEW | 471871202 |
| BNTC | BENITEC BIOPHARMA INC | 62,000 | $725 | 4.9% | $9.63 | +45.2% | COM NEW | 08205P209 |
| GERN | GERON CORP | 500,000 | $705 | 4.8% | $2.31 | -38.7% | COM | 374163103 |
| ARQT | ARCUTIS BIOTHERAPEUTICS INC | 46,300 | $649 | 4.4% | $10.13 | +38.4% | COM | 03969K108 |
| IRON | DISC MEDICINE INC | 10,600 | $561 | 3.8% | $49.93 | -5.9% | COM | 254604101 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 55,000 | $515 | 3.5% | $20.81 | -47.1% | COM | 87164F105 |
| RGNX | REGENXBIO INC | 57,750 | $474 | 3.2% | $15.56 | -46.2% | COM | 75901B107 |
| BHVN | BIOHAVEN LTD | 22,700 | $320 | 2.2% | $38.91 | -54.2% | COM | G1110E107 |
| — | MERSANA THERAPEUTICS INC | 644,000 | $191 | 1.3% | $0.34 | — | COM | 59045L106 |
| MCRB | SERES THERAPEUTICS INC | 17,038 | $189 | 1.3% | $8.80 | 0.0% | COM | 81750R201 |
| HUMA | HUMACYTE INC | 83,500 | $175 | 1.2% | $3.75 | -48.8% | COM | 44486Q103 |